IBDEI2WZ ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,46479,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46479,1,3,0)
 ;;=3^Family Hx Blindness/Visual Loss
 ;;^UTILITY(U,$J,358.3,46479,1,4,0)
 ;;=4^Z82.1
 ;;^UTILITY(U,$J,358.3,46479,2)
 ;;=^5063365
 ;;^UTILITY(U,$J,358.3,46480,0)
 ;;=Z83.518^^176^2312^12
 ;;^UTILITY(U,$J,358.3,46480,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46480,1,3,0)
 ;;=3^Family Hx Other Eye Disorder
 ;;^UTILITY(U,$J,358.3,46480,1,4,0)
 ;;=4^Z83.518
 ;;^UTILITY(U,$J,358.3,46480,2)
 ;;=^5063383
 ;;^UTILITY(U,$J,358.3,46481,0)
 ;;=Z83.511^^176^2312^13
 ;;^UTILITY(U,$J,358.3,46481,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46481,1,3,0)
 ;;=3^Family Hx of Glaucoma
 ;;^UTILITY(U,$J,358.3,46481,1,4,0)
 ;;=4^Z83.511
 ;;^UTILITY(U,$J,358.3,46481,2)
 ;;=^5063382
 ;;^UTILITY(U,$J,358.3,46482,0)
 ;;=H35.3211^^176^2313^1
 ;;^UTILITY(U,$J,358.3,46482,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46482,1,3,0)
 ;;=3^Exudative AMD,RIGHT eye,active CNV
 ;;^UTILITY(U,$J,358.3,46482,1,4,0)
 ;;=4^H35.3211
 ;;^UTILITY(U,$J,358.3,46482,2)
 ;;=^5138521
 ;;^UTILITY(U,$J,358.3,46483,0)
 ;;=H35.3221^^176^2313^2
 ;;^UTILITY(U,$J,358.3,46483,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46483,1,3,0)
 ;;=3^Exudative AMD,LEFT eye,active CNV 
 ;;^UTILITY(U,$J,358.3,46483,1,4,0)
 ;;=4^H35.3221
 ;;^UTILITY(U,$J,358.3,46483,2)
 ;;=^5138525
 ;;^UTILITY(U,$J,358.3,46484,0)
 ;;=H35.059^^176^2313^3
 ;;^UTILITY(U,$J,358.3,46484,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46484,1,3,0)
 ;;=3^Retinal CNV or NV,unspec          
 ;;^UTILITY(U,$J,358.3,46484,1,4,0)
 ;;=4^H35.059
 ;;^UTILITY(U,$J,358.3,46484,2)
 ;;=^5005601
 ;;^UTILITY(U,$J,358.3,46485,0)
 ;;=H35.82^^176^2313^4
 ;;^UTILITY(U,$J,358.3,46485,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46485,1,3,0)
 ;;=3^Retinal Ischemia,unspec           
 ;;^UTILITY(U,$J,358.3,46485,1,4,0)
 ;;=4^H35.82
 ;;^UTILITY(U,$J,358.3,46485,2)
 ;;=^5005716
 ;;^UTILITY(U,$J,358.3,46486,0)
 ;;=H35.81^^176^2313^5
 ;;^UTILITY(U,$J,358.3,46486,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46486,1,3,0)
 ;;=3^Retinal Edema,unspec              
 ;;^UTILITY(U,$J,358.3,46486,1,4,0)
 ;;=4^H35.81
 ;;^UTILITY(U,$J,358.3,46486,2)
 ;;=^5005715
 ;;^UTILITY(U,$J,358.3,46487,0)
 ;;=E11.3211^^176^2313^6
 ;;^UTILITY(U,$J,358.3,46487,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46487,1,3,0)
 ;;=3^DM Type 2 Mild NPDR w/ CME,RIGHT eye    
 ;;^UTILITY(U,$J,358.3,46487,1,4,0)
 ;;=4^E11.3211
 ;;^UTILITY(U,$J,358.3,46487,2)
 ;;=^5138331
 ;;^UTILITY(U,$J,358.3,46488,0)
 ;;=E11.3212^^176^2313^7
 ;;^UTILITY(U,$J,358.3,46488,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46488,1,3,0)
 ;;=3^DM Type 2 Mild NPDR w/ CME,LEFT eye     
 ;;^UTILITY(U,$J,358.3,46488,1,4,0)
 ;;=4^E11.3212
 ;;^UTILITY(U,$J,358.3,46488,2)
 ;;=^5138332
 ;;^UTILITY(U,$J,358.3,46489,0)
 ;;=E11.3311^^176^2313^8
 ;;^UTILITY(U,$J,358.3,46489,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46489,1,3,0)
 ;;=3^DM Type 2 Mod NPDR w/ CME,RIGHT eye     
 ;;^UTILITY(U,$J,358.3,46489,1,4,0)
 ;;=4^E11.3311
 ;;^UTILITY(U,$J,358.3,46489,2)
 ;;=^5138339
 ;;^UTILITY(U,$J,358.3,46490,0)
 ;;=E11.3312^^176^2313^9
 ;;^UTILITY(U,$J,358.3,46490,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46490,1,3,0)
 ;;=3^DM Type 2 Mod NPDR w/ CME,LEFT eye      
 ;;^UTILITY(U,$J,358.3,46490,1,4,0)
 ;;=4^E11.3312
 ;;^UTILITY(U,$J,358.3,46490,2)
 ;;=^5138340
 ;;^UTILITY(U,$J,358.3,46491,0)
 ;;=E11.3411^^176^2313^10
